Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BRM270

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
BACKGROUND/AIM Cervical cancer is one of the leading causes of cancer death in women worldwide. BRM270 (BRMLife) has therapeutic… Expand
Is this relevant?
2019
2019
BRM270 is the most leading phytochemical extract that possesses potent anticancer properties. A major challenge associated with… Expand
Is this relevant?
2019
2019
Pancreatic cancer has a poor survival rate as compared to other types of cancer. Surface marker CD44 plays important role in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2018
2018
Chemotherapy is a standard treatment for non-small-cell lung cancer (NSCLC). However, the dose-limiting toxicity of drugs and the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Hepatocellular carcinoma (HCC) is a major threat to human health worldwide and development of novel antineoplastic drug is… Expand
Is this relevant?
2017
2017
Glioblastoma multiforme (GBM) is one of the most aggressive and lethal human brain tumors, and the median survival of patients… Expand
Is this relevant?
2016
2016
Tumor initiating cancer stem-like cells (TICSCs) have recently become the object of intensive study. Human-Lipocalin-2 (hLCN2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
The nuclear factor κB (NF-κB) and interleukin-6 (IL-6) contribute to multidrug resistance (MDR) in tumor chemotherapy. The… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?